Interestingly, TREM2 has neuroprotective effects in cerebrovascular disease by suppressing TLR4 expression and the downstream NF-κB pathway and suppressing the expression of inflammation-induced cytokines (Liu et al., 2022; Awuah et al., 2025). The gene discussed is TLR4; the disease is cerebrovascular disorder.